Biotechnology

New patent for the drug Azurity EPRONTIA – DrugPatentWatch


Copyright © DrugPatentWatch. Originally published in New patent for the Azurity drug EPRONTIA


Annual Drug Patent Expiration for EPRONTIA

Eprontia is a drug marketed by Azurity and included in one NDA. It is available from a single supplier. There is one patent protecting this drug.

Trends in prices for EPRONTIA drugs.

The generic ingredient in EPRONTIA is topiramate. One registered supplier for this compound. Additional details are available on the topiramate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published in New patent for the Azurity drug EPRONTIA



Source link

Related Articles

Back to top button